In silico analysis of conformational changes induced by mutation of aromatic binding residues: Consequences for drug binding in the hERG K+ channel

25Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Pharmacological inhibition of cardiac hERG K + channels is associated with increased risk of lethal arrhythmias. Many drugs reduce hERG current by directly binding to the channel, thereby blocking ion conduction. Mutation of two aromatic residues (F656 and Y652) substantially decreases the potency of numerous structurally diverse compounds. Nevertheless, some drugs are only weakly affected by mutation Y652A. In this study we utilize molecular dynamics simulations and docking studies to analyze the different effects of mutation Y652A on a selected number of hERG blockers. MD simulations reveal conformational changes in the binding site induced by mutation Y652A. Loss of π-π-stacking between the two aromatic residues induces a conformational change of the F656 side chain from a cavity facing to cavity lining orientation. Docking studies and MD simulations qualitatively reproduce the diverse experimentally observed modulatory effects of mutation Y652A and provide a new structural interpretation for the sensitivity differences. © 2011 Knape et al.

Cite

CITATION STYLE

APA

Knape, K., Linder, T., Wolschann, P., Beyer, A., & Stary-Weinzinger, A. (2011). In silico analysis of conformational changes induced by mutation of aromatic binding residues: Consequences for drug binding in the hERG K+ channel. PLoS ONE, 6(12). https://doi.org/10.1371/journal.pone.0028778

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free